https://youtu.be/UglUrxTyEwI Since its outbreak, coronavirus (COVID-19) has cast an unprecedented impact that has reverberated throughout the world. Scientists, government officials, and doctors have searched frantically for a remedy, to help contain further disruption. In this video, GIOSTAR Co-Founder and Chairman Dr. Anand Srivastava reports on a […]
GIOSTAR Chicago examines glutathione, an extremely powerful antioxidant that helps patients suffering from Parkinson’s disease, diabetes, and numerous other disorders.
GIOSTAR has played a pivotal role in regenerative medicine in India for many years. This trend continues with the launch of a new stem cell / cancer research and therapy center in Chandigarh, one of the country’s most prestigious cities.
GIOSTAR Chicago reviews in greater detail the potential for mesenchymal stem cells (MSCs) to reduce inflammation. This may provide benefit to patients suffering from multiple sclerosis, rheumatoid arthritis, and other autoimmune disorders.
Beyond groundbreaking therapies backed by decades of research, GIOSTAR is a world leader in medical tourism. Learn more about the newest center opening, in the beautiful Cancun Riviera, Mexico.
For more than two decades, Dr. Anand Srivastava and GIOSTAR have been at the forefront of stem cell therapy and research. The company is currently in process of FDA approval for groundbreaking clinical trials regarding Type 2 Diabetes, which impacts roughly 1 in 10 Americans.
IMPORTANT! All information presented in this website is intended for informational purposes only and not for the purpose of rendering medical advice. Statements made on this website have not been evaluated by the Food and Drug Administration. The information contained herein is not intended to diagnose, treat, cure or prevent any disease.
